Announcing an expansion in the USV Board of Directors with the addition of Dr. Aneesha Gandhi Tewari   |    USV's Peg GCSF is approved for the Australian market under the brand name of Filpegla    |   USV obtains marketing authorization for Vildagliptin & Pioglitazone tablets for domestic market through inhouse development   |    USV launches UDAPA S (FDC of Dapagliflozin 10 mg + Sitagliptin 100 mg)    |    The USV Vadodara state-of-the-art formulation plant started commercial supplies in July, 2022, for the leading brand 'Glycomet GP'
pharmaceutical companies in  Mumbai & healthcare industry in india.

We are a 62 year old leading healthcare company which began as a joint venture with USV & P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Peptides, Biosimilars, Injectables and Ophthalmics and Solid Orals. Read More...

Healthcare Company India

© 2024 USV Private Limited. All Rights Reserved.